{"symbol":"SH603367","secucode":"603367.SH","items":[{"title":"辰欣药业：2025年年度权益分派实施公告","summary":"证券日报网讯5月27日，辰欣药业发布2025年年度权益分派实施公告称，本次利润分配以方案实施前的公司总股本452，754，129股为基数，每股派发现金红利0.16元（含税），共计派发现金红利72，440，660.64元。","source":null,"url":"http://finance.eastmoney.com/news/1354,202605273751549037.html","info_code":"NW202605273751549037","show_time_timestamp":1779886680000,"show_time":"2026-05-27 20:58:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202605273751549037.html","url":"http://finance.eastmoney.com/news/1354,202605273751549037.html","code":"202605273751549037","infoCode":"NW202605273751549037","recordId":null,"source":null,"title":"辰欣药业：2025年年度权益分派实施公告","updateTime":0,"showDateTime":1779886680000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯5月27日，辰欣药业发布2025年年度权益分派实施公告称，本次利润分配以方案实施前的公司总股本452，754，129股为基数，每股派发现金红利0.16元（含税），共计派发现金红利72，440，660.64元。"}},{"title":"辰欣药业：将于2026年05月07日召开2025年年度股东大会","summary":"辰欣药业将于2026年05月07日（星期四）下午13:30，在山东省济宁市高新区同济路16号辰欣药业股份有限公司一园区办公楼六楼会议室召开2025年年度股东大会。","source":null,"url":"http://stock.eastmoney.com/news/11671,202605063728589672.html","info_code":"NW202605063728589672","show_time_timestamp":1778054410000,"show_time":"2026-05-06 16:00:10","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://stock.eastmoney.com/a/202605063728589672.html","url":"http://stock.eastmoney.com/news/11671,202605063728589672.html","code":"202605063728589672","infoCode":"NW202605063728589672","recordId":null,"source":null,"title":"辰欣药业：将于2026年05月07日召开2025年年度股东大会","updateTime":0,"showDateTime":1778054410000,"publishDate":0,"sRatingName":null,"summary":"辰欣药业将于2026年05月07日（星期四）下午13:30，在山东省济宁市高新区同济路16号辰欣药业股份有限公司一园区办公楼六楼会议室召开2025年年度股东大会。"}},{"title":"辰欣药业：2026年一季度净利润1.31亿元","summary":"中证智能财讯辰欣药业（603367）4月29日披露2026年第一季度报告。公司实现营业总收入8.5亿元，同比下降7.59%；归母净利润1.31亿元，同比下降8.92%；扣非净利润1.17亿元，同比增长0.48%；经营活动产生的现金流量净额为1.93亿元，同比增长234.77%；报告期内，辰欣药业基本每股收益为0.29元，加权平均净资产收益率为2.09%。","source":null,"url":"http://finance.eastmoney.com/news/1354,202605013727381532.html","info_code":"NW202605013727381532","show_time_timestamp":1777637351000,"show_time":"2026-05-01 20:09:11","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202605013727381532.html","url":"http://finance.eastmoney.com/news/1354,202605013727381532.html","code":"202605013727381532","infoCode":"NW202605013727381532","recordId":null,"source":null,"title":"辰欣药业：2026年一季度净利润1.31亿元","updateTime":0,"showDateTime":1777637351000,"publishDate":0,"sRatingName":null,"summary":"中证智能财讯辰欣药业（603367）4月29日披露2026年第一季度报告。公司实现营业总收入8.5亿元，同比下降7.59%；归母净利润1.31亿元，同比下降8.92%；扣非净利润1.17亿元，同比增长0.48%；经营活动产生的现金流量净额为1.93亿元，同比增长234.77%；报告期内，辰欣药业基本每股收益为0.29元，加权平均净资产收益率为2.09%。"}},{"title":"辰欣药业一季度归母净利润1.31亿元，同比下降8.9%","summary":"4月28日，辰欣药业(603367)公布2026年一季报，公司营业收入为8.5亿元，同比下降7.6%；归母净利润为1.31亿元，同比下降8.9%；扣非归母净利润为1.17亿元，同比上升0.5%；经营现金流净额为1.93亿元，同比增长234.8%；EPS(全面摊薄)为0.2888元。","source":null,"url":"http://stock.eastmoney.com/news/11791,202604283722215795.html","info_code":"NW202604283722215795","show_time_timestamp":1777363500000,"show_time":"2026-04-28 16:05:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202604283722215795.html","url":"http://stock.eastmoney.com/news/11791,202604283722215795.html","code":"202604283722215795","infoCode":"NW202604283722215795","recordId":null,"source":null,"title":"辰欣药业一季度归母净利润1.31亿元，同比下降8.9%","updateTime":0,"showDateTime":1777363500000,"publishDate":0,"sRatingName":null,"summary":"4月28日，辰欣药业(603367)公布2026年一季报，公司营业收入为8.5亿元，同比下降7.6%；归母净利润为1.31亿元，同比下降8.9%；扣非归母净利润为1.17亿元，同比上升0.5%；经营现金流净额为1.93亿元，同比增长234.8%；EPS(全面摊薄)为0.2888元。"}},{"title":"图解财报：辰欣药业一季度归母净利润1.31亿元，同比减少8.92%","summary":"辰欣药业4月29日发布2026年一季报显示，公司一季度实现营业收入8.50亿元，同比下滑7.59%；归母净利润1.31亿元，同比下滑8.92%；扣非归母净利润1.17亿元，同比增长0.48%。免责声明：本文基于AI生产，仅供参考，不构成任何投资建议，据此操作风险自担。东方财富发布此内容旨在传播更多信息，与本平台立场无关。","source":null,"url":"http://stock.eastmoney.com/news/11802,202604283722163243.html","info_code":"NW202604283722163243","show_time_timestamp":1777362154000,"show_time":"2026-04-28 15:42:34","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://stock.eastmoney.com/a/202604283722163243.html","url":"http://stock.eastmoney.com/news/11802,202604283722163243.html","code":"202604283722163243","infoCode":"NW202604283722163243","recordId":null,"source":null,"title":"图解财报：辰欣药业一季度归母净利润1.31亿元，同比减少8.92%","updateTime":0,"showDateTime":1777362154000,"publishDate":0,"sRatingName":null,"summary":"辰欣药业4月29日发布2026年一季报显示，公司一季度实现营业收入8.50亿元，同比下滑7.59%；归母净利润1.31亿元，同比下滑8.92%；扣非归母净利润1.17亿元，同比增长0.48%。免责声明：本文基于AI生产，仅供参考，不构成任何投资建议，据此操作风险自担。东方财富发布此内容旨在传播更多信息，与本平台立场无关。"}}]}